SCHEMBL1680192

SCHEMBL1680192

COc1ccc(C2=C3C=CC(=N3)C(c3ccc(OC)cc3)=C3C=CC(=N3)C(c3ccc(OC)cc3)=C3C=CC(=N3)C(c3ccc(OC)cc3)=C3C=CC2=N3)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ME2 P23368 1/20 0.43
▸ ME1 P48163 1/20 0.43
▸ ME3 Q16798 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA7 P43166 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ CA14 Q9ULX7 1/20 0.42
▸ CLK4 Q9HAZ1 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ TP53 P04637 2/20 0.40
▸ APP P05067 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MAPK1 P28482 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ PKM P14618 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5534014 0.98 ME2 (0.42) ME2ME1ME3CA12CA1
Hydrochloric Acid SCHEMBL15769036 0.96 ME2 (0.41) ME2ME1ME3CA12CA1
SCHEMBL4410281 0.92 ESR2 (0.56) ME2ME1ME3ESR2KDM4E
SCHEMBL11895062 0.85 TNF (0.40) ME2ME1ME3TP53APP
SCHEMBL4266561 0.83 ME2 (0.34) ME2ME1ME3CA12CA1
SCHEMBL498496 0.81 CYP1B1 (0.42) KDM4EMAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7261654 0.81 CYP19A1 (0.41) KDM4EMAPTTP53APPKMT2A
SCHEMBL17681578 0.81 CASP3 (0.42) MAPTNPC1RAB9ACASP3SENP8
SCHEMBL433808 0.79 DYRK1A (0.49) CLK4KDM4EMAPTTP53KMT2A
SCHEMBL9718812 0.78 HPGD (0.38) KDM4EKMT2AMEN1TDP1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12377405-B2 Synthesis of metal complexes and uses thereof NOVOMER, INC. (US) 2025-08-05 — — US disclosed
US-12122939-B2 Antibacterial polymer coating composition and antibacterial polymer film LG CHEM, LTD. (KR) 2024-10-22 — — US disclosed
EP-3965928-B1 PROCESS FOR PREPARING POLYPROPYLENE CARBONATE ENI SPA (IT) 2024-07-03 — — EP disclosed
US-11958986-B2 Antibacterial polymer coating composition and antibacterial polymer film LG CHEM, LTD. (KR) 2024-04-16 — — US disclosed
US-11935803-B2 Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2024-03-19 — — US disclosed
EP-3795647-B1 ANTIBACTERIAL POLYMER COATING COMPOSITION AND ANTIBACTERIAL POLYMER FILM LG CHEMICAL LTD (KR) 2023-12-27 — — EP disclosed
EP-3171976-B1 SYNTHESIS OF METAL COMPLEXES AND USES THEREOF NOVOMER INC (US) 2023-09-06 — — EP disclosed
EP-3578616-B1 ANTIMICROBIAL POLYMER COATING COMPOSITION AND ANTIMICROBIAL POLYMER FILM LG CHEMICAL LTD (KR) 2023-05-17 — — EP disclosed
US-11578179-B2 Antimicrobial polymer coating composition and antimicrobial polymer film LG CHEM, LTD. (KR) 2023-02-14 — — US disclosed
EP-3569662-B1 ANTIMICROBIAL POLYMER COATING COMPOSITION AND ANTIMICROBIAL POLYMER FILM LG CHEMICAL LTD (KR) 2022-12-28 — — EP disclosed
US-20140077120-A1 Magnetically Enhanced Resin Tanaka Seimitsu Kogyo Co.Ltd. (JP) 2014-03-20 — — US disclosed
EP-2489089-B1 METHOD FOR PRODUCING ELECTRODE CATALYST FOR FUEL CELL TOYOTA MOTOR CO LTD (JP) 2013-09-18 — — EP disclosed
EP-2489089-A1 METHOD FOR PRODUCING ELECTRODE CATALYST FOR FUEL CELL Toyota Jidosha Kabushiki Kaisha (JP) 2012-08-22 — — EP disclosed
US-20120196738-A1 METHOD FOR PRODUCING ELECTRODE CATALYST FOR FUEL CELL HELMHOLTZ-ZENTRUM BERLIN FUER MATERIALIEN UND ENERGIE GMBH (DE) 2012-08-02 — — US disclosed
WO-2011045869-A1 METHOD FOR PRODUCING ELECTRODE CATALYST FOR FUEL CELL TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) 2011-04-21 — — WO disclosed
EP-1741694-A1 METHOD FOR PRODUCING CYCLOALKANOL AND/OR CYCLOALKANONE Sumitomo Chemical Company, Limited (JP) 2007-01-10 — — EP disclosed
US-20040076585-A1 Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers GONG XIANCHANG (US) 2004-04-22 — — US disclosed
US-20030232982-A1 Method to prepare porphyrin nanoparticles and its application as oxidation catalyst GONG XIANCHANG (US) 2003-12-18 — — US disclosed
EP-0733901-A2 Gas reactive pigment, gas detector using the same, and gas detection method and apparatus using the detector EBARA CORPORATION (JP) 1996-09-25 — — EP disclosed
EP-0283754-A2 Tungsten oxo-porphyrin complexes Degussa Aktiengesellschaft (DE) 1988-09-28 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12377405-B2 Synthesis of metal complexes and uses thereof ALOX5, ALOX15B, AP1M1 ME2 1592/4885ME1 905/4885ME3 801/4885
US-20040076585-A1 Nanoparticles of cyclic tetrapyrrolic compounds as gene and drug delivery carriers CCDC6, CCDC47, ABCB1 ME2 3441/4885ME1 3445/4885ME3 2443/4885
US-20030232982-A1 Method to prepare porphyrin nanoparticles and its application as oxidation catalyst PPOX, HMOX2, CYP3A43 ME2 2116/4885ME1 3561/4885ME3 941/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback